Oligonucleotide/Aptamer Development At The Interface Of Material, Life And Information Sciences

Nucleic-acid-based therapies, including ssDNA aptamers, siRNA, and mRNA, represent high-value payloads in cell and gene therapy development. Protecting the integrity of these sensitive molecules is critical, yet material selection for storage and handling often presents a challenge.

Join speakers Julien Muzard and Mark Platt as they explore how fluoropolymer film offers a significant advantage as a material of choice for the development and manufacture of these therapies. They outline the steps for integrating appropriate materials and tools for oligonucleotide handling, focusing on the optimization of DNA storage using dedicated fluoropolymer films. Additionally, you'll learn about the importance and application of highly sensitive assays for the detection and prevention of nucleic acid and particle contamination.

Don't let material incompatibility compromise your high-value payloads. Watch below to learn how to enhance the safety and stability of your oligonucleotide therapies.